ReviewCurrent oncology (Toronto, Ont.)2023

Prospective Clinical Trials to Advance the Study of Immune Checkpoint Inhibitor Toxicity.

Christopher Cluxton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.